TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis-Reference-Cited by-同舟云学术

TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis

Published:2019-11-10 Issue:12 Volume:15 Page:1303-1312
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Lubrano Ennio¹,Scriffignano Silvia¹,Perrotta Fabio Massimo¹

Affiliation:

1. Academic Rheumatology Unit. Dipartimento di Medicina e Scienze della salute “Vincenzo Tiberio”, Università degli Studi del Molise, Campobasso, Italy

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2020.1685382

Reference95 articles.

1. Psoriatic Arthritis

2. Role of comorbidities in spondyloarthritis including psoriatic arthritis

3. Non-Antigen-Specific CD8+ T Suppressor Lymphocytes in Diseases Characterized by Chronic Immune Responses and Inflammation

4. The pathogenesis of psoriatic arthritis

5. A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review;Current Rheumatology Reports;2024-06-20

2. Planarized through-hole valves enabling multilayered microfluidic architecture towards pipette-free ELISA;Microchemical Journal;2024-05

3. Assessment of Patient–Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study;Rheumatology and Therapy;2024-03-06

4. Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis;Rheumatology and Therapy;2023-09-16

5. A Patient with Adalimumab-Induced Refractory Paradoxical Palmoplantar Pustulosis Was Successfully Treated by Ixekizumab: A Case Report;Clinical, Cosmetic and Investigational Dermatology;2023-04